ABSTRACT
Hypothalamic hamartomas (HHs) are associated with treatment-resistant epilepsy. Many patients also experience severe and sometimes disabling psychiatric problems. The most common behavioral symptoms consist of paroxysms of uncontrolled anger related to poor frustration tolerance. These can include violence, resulting in disrupted family or school relationships, and legal consequences including incarceration. In a large cohort of patients undergoing surgical resection of HHs for refractory epilepsy, 88% of families described an improvement in overall behavioral functioning [1]. Here, we describe four patients (three males, mean age=11.9 years) who underwent surgical resection of HHs largely for behavioral indications. Three patients had relatively well controlled seizures, and one had no history of epilepsy. All patients had striking improvement in their psychiatric comorbidity. HH resection can result in significant improvement in behavioral functioning, even in patients with relatively infrequent seizures. Further investigation under approved human research protocols is warranted.
Subject(s)
Brain/surgery , Epilepsy/surgery , Mental Disorders/surgery , Adolescent , Child , Epilepsy/etiology , Female , Hamartoma/complications , Hamartoma/surgery , Humans , Hypothalamic Diseases/complications , Hypothalamic Diseases/surgery , Male , Mental Disorders/etiology , Treatment OutcomeABSTRACT
BACKGROUND/AIMS: Hypothalamic hamartomas are the most common identifiable cause of central precocious puberty (CPP). Hamartoma characteristics proposed to be associated with CPP include specific anatomic features and expression of molecules such as gonadotropin-releasing hormone (GnRH), transforming growth factor alpha (TGFalpha), and GRM1A, which encodes the type 1 metabotropic glutamate receptor alpha isoform. We sought to determine whether hamartomas that cause CPP could be distinguished by anatomic features, expression of these molecules, or expression of KISS1, whose products signal through the receptor GPR54 to stimulate GnRH release. METHODS: Clinical records and radiologic images were reviewed for 18 patients who underwent hamartoma resection for intractable seizures; 7 had precocious puberty. Resected tissue was examined for expression of GnRH, GnRH receptor (GnRHR), TGFalpha, KISS1, GPR54, and GRM1A. RESULTS: Hypothalamic hamartomas associated with CPP were more likely to contact the infundibulum or tuber cinereum and were larger than hamartomas not associated with CPP. GnRH, TGFalpha, and GnRHR were expressed by all hamartomas studied. Expression of KISS1, GPR54, and GRM1A did not differ significantly between hamartomas associated and not associated with CPP. CONCLUSION: Anatomic features rather than expression patterns of candidate molecules distinguish hypothalamic hamartomas that are associated with CPP from those that are not.
Subject(s)
Gonadotropin-Releasing Hormone/biosynthesis , Hamartoma/complications , Hypothalamic Diseases/complications , Puberty, Precocious/etiology , Transforming Growth Factor alpha/biosynthesis , Tumor Suppressor Proteins/biosynthesis , Adolescent , Child , Child, Preschool , Female , Gene Expression , Hamartoma/diagnostic imaging , Hamartoma/metabolism , Hamartoma/pathology , Hamartoma/surgery , Humans , Hypothalamic Diseases/diagnostic imaging , Hypothalamic Diseases/pathology , Infant , Kisspeptins , Male , Puberty, Precocious/pathology , Radiography , Receptors, LHRH/biosynthesis , Seizures/etiology , Seizures/surgeryABSTRACT
Hypothalamic hamartomas (HHs) are rare developmental tumors that cause seizures or pituitary axis dysfunction, usually beginning in childhood. We analyzed HH tissue from 57 patients whose tumors were resected through recently developed transcallosal interforniceal and transventricular endoscopic surgical approaches. All cases were composed of abnormally distributed but cytologically normal neurons and glia, including fibrillary astrocytes and oligodendrocytes. Neuronal elements predominated in most cases, but a relative increase in astrocytic elements was seen with increasing age. All had various sized nodular foci of neurons as well as areas of diffusely distributed neurons with interspersed glial cells. Smaller neurons predominated, and most cases had only a few interspersed large ganglion cells. Immunohistochemistry demonstrated extensive production of synapse-associated proteins. Immunohistochemistry for phosphorylated and nonphosphorylated neurofilament and alpha-internexin demonstrated staining patterns consistent with mature neurons. In contrast to cortical dysplasia, atypical large ganglion-like balloon cells were almost never seen. In summary, although their number and distribution vary, mature smaller neurons were the most prominent and most consistent histologic feature of HH. Nodules of these small neurons were a universal feature of the microarchitecture of HH lesions associated with epilepsy. Characterization of these neurons may aid in understanding the mechanism of seizure development in HH.
Subject(s)
Hamartoma/pathology , Hypothalamic Diseases/pathology , Hypothalamus/abnormalities , Hypothalamus/pathology , Adolescent , Adult , Astrocytes/cytology , Astrocytes/metabolism , Biomarkers/metabolism , Child , Child, Preschool , Epilepsy/etiology , Epilepsy/pathology , Epilepsy/physiopathology , Female , Hamartoma/metabolism , Hamartoma/physiopathology , Humans , Hypothalamic Diseases/metabolism , Hypothalamic Diseases/physiopathology , Hypothalamus/physiopathology , Immunohistochemistry , Infant , Male , Middle Aged , Nerve Tissue Proteins/metabolism , Neurons/cytology , Neurons/metabolism , Neuropil/cytology , Neuropil/metabolismABSTRACT
PURPOSE: To present the results of transcallosal surgical resection of hypothalamic hamartoma (HH) in 26 patients with refractory epilepsy in a prospective outcome study. METHODS: Patients with refractory epilepsy symptomatic to HH were referred for surgical resection of their HH (mean age, 10.0 years; range, 2.1-24.2 years). A transcallosal, interforniceal approach was used to remove and/or disconnect the hamartoma. Volumetry was obtained on pre- and postoperative brain MRI scans to determine percentage of resection. Outcome assessment included determination of postoperative seizure frequencies in comparison to baseline and the incidence of postoperative complications. Postoperative changes in cognitive and behavioral functioning, in comparison to baseline, were elicited by parental report. RESULTS: The average postoperative follow-up interval was 20.3 months (range, 13-28 months). Fourteen (54%) patients were completely seizure free, and nine (35%) had at least a 90% improvement in total seizure frequency. Parents reported postoperative improvement in behavior in 23 (88%) patients and in cognition in 17 (65%) patients. Transient postoperative memory disturbance was seen in 15 (58%) patients, but persisted in only two (8%). Two (8%) patients had persisting endocrine disturbance requiring hormone replacement therapy (diabetes insipidus and hypothyroidism in one each). With univariate analysis, the likelihood of a seizure-free outcome correlated with younger age, shorter lifetime duration of epilepsy, smaller preoperative HH volume, and 100% HH resection. CONCLUSIONS: Refractory epilepsy associated with HH can be safely and effectively treated with surgical resection by a transcallosal, interforniceal approach. Short-term memory deficits appear to be transient for most patients, and family perception of the impact of surgery on cognitive and behavioral domains is favorable. Complete resection yields the best result.
Subject(s)
Corpus Callosum/surgery , Epilepsy/surgery , Hamartoma/surgery , Hypothalamic Diseases/surgery , Neurosurgical Procedures/methods , Adolescent , Adult , Age Factors , Attitude to Health , Child , Child, Preschool , Corpus Callosum/pathology , Epilepsy/pathology , Family/psychology , Female , Follow-Up Studies , Hamartoma/pathology , Humans , Hypothalamic Diseases/pathology , Hypothalamus/pathology , Hypothalamus/surgery , Magnetic Resonance Imaging , Male , Memory Disorders/epidemiology , Microsurgery/methods , Stereotaxic Techniques , Survival Analysis , Treatment OutcomeABSTRACT
The authors report the case of a 12-year-old girl with Pallister-Hall syndrome, long-standing refractory, symptomatic epilepsy, mental retardation, and panhypopituitarism in whom two rare, deep midline lesions were detected. She underwent successful transsphenoidal resection of the Rathke cleft cyst and transcallosal resection of the hypothalamic hamartoma within a 4-day period without complications. Neuropathological studies confirmed the neuroimaging diagnoses for the two lesions. The patient has been seizure free for 6 months postoperatively.